FGF23 and chronic kidney disease: In addition, the development of therapeutic strategies to raise α-Klotho and lower phosphate, FGF23, and other uremic toxins is of great importance as they may contribute to the decline in cardiovascular morbidity and mortality in CKD and after kidney transplantation.